Gonzalo Gonzalez-Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gonzalo Gonzalez-Silva has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Albert Blanco-Grau
Biochemistry Department, Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain
1 shared publication - Andrea Arias-García
Clinical Biochemistry Department , Drug Delivery and Therapy Research Group, Vall d’Hebron Research Institute (VHIR), Vall d’Hebron University Hospital , Barcelona , Spain
1 shared publication - Andrea Caballero
Clinical Biochemistry Department , Drug Delivery and Therapy Research Group, Vall d’Hebron Research Institute (VHIR), Vall d’Hebron University Hospital , Barcelona , Spain
1 shared publication - Celia Monteagudo-Lopez
Clinical Biochemistry Department , Drug Delivery and Therapy Research Group, Vall d’Hebron Research Institute (VHIR), Vall d’Hebron University Hospital , Barcelona , Spain
1 shared publication - Clara Sanz Gea
Clinical Lab Hospital Universitari Vall d'Hebron Barcelona Spain
1 shared publication Fernando Moreno
Clinical Biochemistry Department , Drug Delivery and Therapy Research Group, Vall d’Hebron Research Institute (VHIR), Vall d’Hebron University Hospital , Barcelona , Spain
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 7 (1) , 34-42
Calculation of reference intervals using an indirect approach from laboratory database
Objectives: The establishment of reference intervals (RIs) for biochemical parameters is crucial for the accurate interpretation of laboratory test results and clinical decision-making. This study aims to evaluate the feasibility of determining RIs using an indirect approach, which analyzes routine clinical samples instead of recruiting healthy individuals, thus leveraging large datasets while applying strict statistical criteria to exclude pathological values. Methods: This is a prospective study in which patients fulfilling inclusion criteria were recruited from the routine primary care to achieve a high proportion of healthy individuals. Biochemical magnitudes as creatinine, esterified bilirubin, ferritin, and transferrin were analyzed. A patient exclusion protocol was implemented to minimize results suggestive of pathology but ensuring a sufficient sample size for the calculation of new RIs. The new ones were compared with the RIs used in the laboratory, provided by the manufacturer. Results: The comparison between the newly calculated RIs and the existing laboratory RIs did not reveal statistically significant differences. The indirect approach provided robust RIs while maintaining data quality and a sufficient sample size. Conclusions: The findings support the effectiveness of this indirect approach for RI determination, provided that rigorous data quality standards and adequate sample sizes are maintained. The adoption of these RIs in clinical practice could enhance diagnostic accuracy and optimize healthcare resource utilization.
- 1 September 2025
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 7 (1) , 34-42
Open AccessCalculation of reference intervals using an indirect approach from laboratory database
Objectives: The establishment of reference intervals (RIs) for biochemical parameters is crucial for the accurate interpretation of laboratory test results and clinical decision-making. This study aims to evaluate the feasibility of determining RIs using an indirect approach, which analyzes routine clinical samples instead of recruiting healthy individuals, thus leveraging large datasets while applying strict statistical criteria to exclude pathological values. Methods: This is a prospective study in which patients fulfilling inclusion criteria were recruited from the routine primary care to achieve a high proportion of healthy individuals. Biochemical magnitudes as creatinine, esterified bilirubin, ferritin, and transferrin were analyzed. A patient exclusion protocol was implemented to minimize results suggestive of pathology but ensuring a sufficient sample size for the calculation of new RIs. The new ones were compared with the RIs used in the laboratory, provided by the manufacturer. Results: The comparison between the newly calculated RIs and the existing laboratory RIs did not reveal statistically significant differences. The indirect approach provided robust RIs while maintaining data quality and a sufficient sample size. Conclusions: The findings support the effectiveness of this indirect approach for RI determination, provided that rigorous data quality standards and adequate sample sizes are maintained. The adoption of these RIs in clinical practice could enhance diagnostic accuracy and optimize healthcare resource utilization.